LV Distension and ECLS Lungs Kevin W. Hatton, MD, FCCM Interim Vice-Chair for Anesthesiology Research Division Chief, Anesthesiology Critical Care Medicine Program Director, Anesthesiology Critical Care Medicine Fellowship Associate Clinical Professor of Anesthesiology and Surgery University of Kentucky College of Medicine
Faculty Disclosure • Neither I nor my spouse have any conflicts to disclose.
Educational Need/Practice Gap • Gap = The decision to use VA-ECLS must be carefully weighed against possible complications. There are several possible adverse events that can occur and the practitioner should be aware of the most common. • Need = The desired change/result in practice is to be aware of the different indications and possible complications for VA ECLS.
Objectives Upon completion of this educational activity, you will be able to: 1. Indicate the mechanisms for LV distension. 2. Describe the impact of LV distension on the patient.
Expected Outcome • At the end of this presentation, learners will be able to: • Explain the mechanism for LV distension in VA ECLS • Describe the common complications of LV distension in VA ECLS • Devise a treatment plan for LV distension in VA ECLS
Introduction • 68 year old male • Admitted with SOB and fatigue • Diagnosed with acute myocarditis • Despite IABP and inotropic support, developed worsening cardiogenic shock • Placed on peripheral VA ECLS • Initial improvement but oxygenation worsens 1-2 days later Image from: Soleiani. Perfusion. 2012;27:326.
VA ECMO • ECLS Venous Drainage = RA drained via catheter placed in femoral vein • Allows significant decompression of right atrium and right ventricle • Left ventricle continues to fill with blood • Some blood passes around the RA drainage catheter to the RV • Some blood passes through collateral flow between bronchial and pulmonary arterial circulatory systems Image from: https://twitter.com/ELSOOrg/status/1008426052505522176
Retrograde Aortic Blood Flow https://twitter.com/ELSOOrg/status/1008426052505522176 https://openi.nlm.nih.gov/detailedresult.php?img=PMC3968595_CCR-10-65_F1&req=4
LV Distension • Retrograde flow results in marked increase in LV afterload • In failing LV, increased afterload may have direct effect on LV function • Increased LV wall stress and myocardial O2 consumption • LV and LA blood stasis and intra-cardiac thrombosis • In addition, incompetent mitral valve may improve LV distension but may lead to pulmonary edema • Increased LV dilatation • Increased LA pressure • Pulmonary edema
Risk Factors for LV Distension • High pulmonary venous return to LV due to inadequate drainage from RA into the ECMO circuit • Incorrect ECMO settings • Inappropriately placed RA cannula • Intrinsically high collateral blood flow between bronchial and pulmonary circulations • Failure of aortic valve to open • Absence of functional MR allowing retrograde LV off-loading • Aortic valve incompetency
Definition of LV Distension 121 patients requiring VA ECMO at single academic medical center LV Distension (LVD) defined by: • Radiographic pulmonary edema • PADBP > 25 mmHg 36 patients developed LVD (29.8%) • 9 treated with early LV decompression Image from: Truby. ASAIO J. 2017;63:257.
Diagnostic Options • Clinical diagnosis • Chest radiography • ECHO (TTE or TEE) • Swan-Ganz Catheter • Serial BNP measures Image from: http://clipart-library.com/clipart/399334.htm
TEE Images of LV Distension Images from: Soleiani. Perfusion. 2012;27:326.
Treatment of LV Distension The most important treatment to prevent complications of LV distension is to rapidly decompress LV. Image from: http://clipart-library.com/clipart/2703.htm
Conservative Treatment of LV Distension • Conservative therapies • Exclude mechanical problems with ECMO • TTE to evaluate cannula positions • Aggressive diuretic therapy to reduce systemic overload • Inotropic therapy to improve myocardial function
Mechanical Treatment of LV Distension • IABP counter-pulsation • Atrial septal defect • Percutaneous atrial septostomy • Surgical septostomy • LV venting procedures • Open surgical procedure • Minimally-invasive procedures • Percutaneous procedures Image from: http://clipart-library.com/clipart/8izrdaL4T.htm
Published Venting Studies Image from: Meani. Eur J Heart Failure Suppl. 2017;19:84.
ECLS and IABP Image from: Cheng. J Invasive Cardiol. 2015;27:453.
LV Venting Procedures • Surgical LV Vent Procedure • Most commonly used in patients with central cannulation • Catheter placed through right superior pulmonary vein into LA or LV • Connected with Y-connector to drainage side of ECLS circuit • Transfemoral LV cannula drainage • Impella 2.5 (Abiomed, Danvers, MA) • TandemHeart (CardiacAssist, Pittsburgh, PA)
Transfemoral Percutaneous LV Cannula Images from: Hong. ASAIO J. 2016;62:117.
Edema Improved by Transfemoral Cannula Images from: Hong. ASAIO J. 2016;62:117.
LV Distension Improved by Impella Device • Case series of 5 patients requiring peripheral VA ECLS • Impella 2.5 placed within 6 hours of VA ECLS in contralateral femoral artery • PCWP > 18 mmHg • Absent aortic valve opening • Enlarged LV on TEE • Impella titrated to PCWP < 12 mmHg Image from: Cheng. ASAIO J. 2013;59:533.
Future Directions 1. Optimize definition of LV distension in ECLS patients 2. Define population of ECLS patients who will benefit from LV decompression procedure 3. Define optimum LV decompression procedure
Conclusions • LV distension is common in patients requiring peripheral VA ECLS for cardiogenic shock • LV distension occurs because retrograde aortic blood flow significantly increases LV afterload • LV distension may cause: • Increased LV wall stress, chamber diameter and myocardial O2 consumption • LV and LA blood stasis and intra-cardiac thrombosis • LA enlargement, pulmonary venous congestion and pulmonary edema
Conclusions • LV distension is primarily diagnosed with TEE but can also be seen through elevations in CVP, PAWP, and PADBP • The treatment of LV distension is LV decompression: • Conservative treatments • IABP counter-pulsations • Surgical LV decompression • Percutaneous LV decompression
DEEP LEARNING FRAMEWORK FOR DIAGNOSTICS AND PATIENT-SPECIFIC DESIGN OF BIOPROSTHETIC HEART VALVES ADITY TYA A BALU SAHI HITI TI NALL LLAGOND GONDA MING NG-CHEN HEN HSU SOUM UMIK SARKAR RKAR ADAR ARSH SH KRISH SHNAM AMUR URTH
727 views • 50 slides
Optimizing Outcomes For Frail High Risk Seniors Through Specialist-Specialist and Primary Care- Specialist Collaborative Models RGPs of Ontario Ottawa Transcatheter Aortic Valve Insertion (TAVI) program (Presentation 1) Dr. Allen Huang The
603 views • 16 slides
Pharm acovigilance Joint plenary of PCWP and HCPWP: September 2019 Dr Peter Arlett Head of Pharm acovigilance and Epidem iology Departm ent EMA An agency of the European Union W hat do w e do? Facilitate Evaluate developm ent m arketing
610 views • 15 slides
Safety, Tolerability and Transthyretin Stabilization by AG10: A Phase 2, Randomized, Double-blind, Placebo-controlled Clinical Trial in Patients with Transthyretin Amyloid Cardiomyopathy and NYHA Class II/III Heart Failure Judge, Daniel P; Falk,
173 views • 14 slides
A Multistate Analysis of the Readmission Rates for Isolated Aortic Valves Replacement Natalia S. Ivascu, Zachary A. Turnbull, Gregory P. Giambrone, Jonathan M. Eskreis- Winkler, Akshay U. Bhat, Ramin Zabih, Peter M. Fleischut Introduction
259 views • 8 slides
See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/263397403 Atrioventricular block as the initial presentation of calcified bicuspid aortic valve Article in ARYA Atherosclerosis
280 views • 7 slides
ANNUAL OCT. 31-NOV. 2, 2017 MEETING ARLINGTON, VA Implementing Shared Decision-Making for Patients with Aortic Valve Disease Susan Strong J. Matthew Brennan, MD MPH Patient Representative Interventional Cardiology Denver, CO Duke
332 views • 11 slides
Toronto Aortic Stenosis Quality of Life Scale (TASQ): Development of a Scale Based on a Canadian Aortic Stenosis Population and TAVI Patients RIMA STYRA, MICHELLE DIMAS, MAMTA KAPOOR, KATHY SVITAK, MARK OSTEN, MARAL OUZOUNIAN, GERALD DEVINS,
458 views • 21 slides
Overview of the Data Center William M. DeCampli MD, PhD Congenital Heart Surgeons Society Data Center The Hospital for Sick Children, Toronto, CA The Heart Center at Arnold Palmer Hospital for Children University of Central Florida College of
1.14k views • 109 slides
ECMO. In the Emergency Department John C. Greenwood, MD Department of Emergency Medicine University of Maryland School of Medicine Baltimore, MD Objectives At the end of this presentation, the participant will be able to: Understand
333 views • 5 slides
Tirone David-V S mod V-SARR for Bicuspid Aortic Valve (BAV) Aortopathy and AR Stanford University CV Surgery Tirone David-V S mod V-SARR for Bicuspid Aortic Valve (BAV) Aortopathy and AR FUNDAMENTALS: 1. Pathoanatomy of different types of
782 views • 62 slides
Late Presentation of Turner Syndrome and Its Complications Huzairi Sani 1 , Nada Syazana Zulkufli 2 1 Faculty of Medicine, Universiti Teknologi MARA, Selangor, Malaysia 2 Department of Pathology, Selayang Hospital, Selangor, Malaysia Received
69 views • 5 slides
BASIC ECHOCARDIOGRAPHY HOW TO DO? Before echocardiography Patients clinical data Symptoms - Why do we examine? Chest pain, dyspnea, etc. Blood pressure Past medical history HTN, IHD,
1.15k views • 81 slides
En Endo docardit carditis is De Deba bate: te: IV to P.O. IV to P.O. or IV to or IV to N.O. N.O. Maureen Campion, PharmD, BCIDP Kirthana Beaulac, PharmD, BCPS UMass Memorial Medical Center Tufts Medical Center Ob Objec ectives
573 views • 55 slides
Faculty Disclosures Perioperative Management of Warfarin Interruption There are no actual or potential conflicts of interest associated with Victoria Lambert, PharmD, CACP this presentation. Medication Management Pharmacist William W.
518 views • 12 slides
Adult Congenital Heart Disease Pankaj Madan, MD, MS, Medical Director South Texas Adult Congenital Heart Center Methodist Hospital, San Antonio Which statement is FALSE about congenital heart disease population? 1. More children than adults
771 views • 45 slides
Fetal Cardiac Fin indings in in Rats Exposed to Tri richloroethylene (T (TCE) in in Dri rinking Water John M. DeSesso 1 , Christopher Bevan 2 , James S. Bus 1 1 Exponent, 2 Halogenated Solvents Industry Alliance Presented to: United States
848 views • 26 slides
Challenging Cases in Cardiology with Your Participation Kuwait IM Course, Kuwait City March 2019 Duane Pinto, MD, MPH, FACC Director, Cardiac Intensive Care Unit Director, Interventional Cardiology Section Beth Israel Deaconess Medical Center
587 views • 24 slides
Independent Living with Medical Technologies Valentina Ancona Senior Manager Government Affairs & Public Policy MedTech Europe This project has received funding from the European Unions Horizon 2020 research and innovation programme
546 views • 7 slides
Title of presentation Organ and Tissue Donation Title of presentation Jenny Duggan Communications Officer 9222 8556 Jennifer.firstname.lastname@example.org DonateLife WA Agency for Organ & Tissue Donation 2 Title of presentation Organ
575 views • 26 slides
Presentation of the Cardiac Surgery Simulation Syllabus to the Thoracic Surgery Directors Association A Comprehensive 6 Module Curriculum for Simulation Based Training in Cardiac Surgery from the AHRQ Cardiac Surgery Simulation Training Grant
911 views • 28 slides
5/2/13 Outline Mul$lingualism and Aphasia Defini,on of mul,lingualism How languages are affected by aphasia Recovery paBerns Treatment for
170 views • 4 slides
TREATMENT FOR GLOBAL APHASIA: Current Perspec;ves of SLT s & A Novel Cogni;ve Approach SH SHARON A ADJEI JEI SL SLT/ UC UCL
602 views • 19 slides
Direct Service at A.I. Presentation to Board Rochelle Cohen-Schneider M.Ed ( reg. CASLPO) January 30th th , 2017 Aphasia has a serious impact and affects 1/3 of stroke patients Based on extrapolation from current stroke stats *, there are
596 views • 25 slides